TFF Pharmaceuticals and Cleveland Clinic to begin preclinical testing of universal influenza vaccine candidates
May 21, 2024
TFF Pharmaceuticals Inc. has announced it is advancing into preclinical testing multivalent universal influenza vaccine candidates to protect against seasonal and pandemic viruses, in collaboration with Cleveland Clinic.
